June 3, 2014
SEATTLE –– NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced that it has entered into a collaboration with Celgene Corporation to develop a companion diagnostic assay using the nCounter® Analysis System to support the clinical validation of REVLIMID® for treatment of Diffuse Large B-Cell [...]
June 3, 2014
WALTHAM, Mass.-- PerkinElmer, Inc., (NYSE: PKI), a global leader focused on the health and safety of people and the environment, today announced an agreement to serve as the exclusive collaborator with China's National Health and Family Planning Commission (NHFPC) in developing and implementing an extensive three-year newborn screening training program focused on early detection of [...]
FEI and University of Manchester Announce Collaboration Agreement for Metals Research
June 2, 2014
Hillsboro, Ore., U.S. and Manchester, U.K. -—FEI (NASDAQ: FEIC) and The University of Manchester announce their collaboration on the Metals Lab at The University of Manchester’s Electron Microscopy Centre in the School of Materials. The lab will focus on steels and non-ferrous alloys research in an effort to develop high-performance materials for use in automotive, [...]
Indigo Capital Raise and Leadership Change
June 2, 2014
INDIANAPOLIS -- Indigo Biosystems (Indigo), the industry leading data review software developer for clinical, reference, and research laboratories, announced the closing of its $8.5 million round of funding today. The investment will be used to support the company’s rapid growth as well as invest in the research and development of future products and new markets. [...]
June 2, 2014
Cambridge, UK –– Cresset, innovative provider of computational chemistry software and services, is pleased to announce that the Centre for Chemical Biology and Therapeutics (CCBT) at The Institute for Stem Cell Biology and Regenerative Medicine (inStem), a state-of-the-art research institute in Bangalore, India, has taken a three year license for use of Cresset’s Forge and [...]
June 2, 2014
CAMBRIDGE, Mass. –– Scientists at Nuclea Biotechnologies, Inc. and Thermo Fisher Scientific are pooling their expertise to develop novel multiplexed research methods for high-throughput quantification of native insulin and its therapeutic analogs. Monitoring the levels of these markers may be useful in predicting the response to therapy for Type 2 diabetes. Nuclea has extensive experience [...]
Inframatic 9500 approved in Austria
June 2, 2014
Stockholm, Sweden -- The IM 9500 NIR Grain Analyzer has been officially approved by the BEV(Bundesamt für Eich- und Vermessungswesen), the national metrology institute providing scientific and technical services in Austria. BEV has evaluated the IM 9500 and concluded that it meets the requirements for official determination of moisture. With this approval, number 3904/2013, the [...]
Avantor Performance Materials Names William E. Redmond, Jr. to Board of Directors
June 2, 2014
CENTER VALLEY, PA -- Avantor™ Performance Materials, a global manufacturer and supplier of high-performance chemistries, announces the appointment of William E. Redmond, Jr. to its Board of Directors. Mr. Redmond brings extensive experience to the Avantor Board of Directors. In his career, Mr. Redmond has served as a chief executive officer or director of more [...]
DefiniGEN announces closing of £2.3 million ($3.8 million) Series A Fundraising
June 2, 2014
DefiniGEN Ltd, a leading provider of stem cell life science products and services, today announced the final closing of its Series A funding round. The latest £1 million ($1.6 million) placement for ordinary shares brings to a close a cumulative total for the round of £2.28 million ($3.83 million), which will support the international expansion [...]
Roche acquires Genia Technologies to strengthen next generation sequencing pipeline
June 2, 2014
Basel -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the acquisition of Genia Technologies, Inc. (Genia), a privately held company, based in Mountain View, California, USA. Genia is developing a single-molecule, semiconductor based, DNA sequencing platform using nanopore technology. Under the terms of the agreement, Roche will pay Genia’s shareholders USD 125 million in [...]
